Because the synthetic mRNA in the vaccine has been programmed to instruct your cells to produce an unnatural, genetically engineered spike protein. Specific alterations make it far more toxic than that found on the virus itself. Mikovits goes so far as to call the spike protein a bioweapon, as it is a disease-causing agent that demolishes innate immunity and exhausts your natural killer (NK) cells’ ability to determine which cells are infected and which aren’t.
In short, when you get the COVID-19 vaccine, you are being injected with an agent that instructs your body to produce the bioweapon in its own cells. This is about as diabolical as it gets.
In her paper, “Worse Than The Disease: Reviewing Some Possible Unintended Consequences of mRNA Vaccines Against COVID-19,” published in the International Journal of Vaccine Theory, Practice and Research in collaboration with Dr. Greg Nigh,16 Seneff explains why the unnatural spike protein is so problematic.
In summary, normally, the spike protein on a virus will collapse on itself and fall into the cell once it attaches to the ACE2 receptor. The vaccine-induced spike protein does not do this. Instead it stays open and remains attached to the ACE2 receptor, thereby disabling it and causing a host of problems that lead to heart, lung and immune impairment.
What’s more, because the RNA code has been enriched with extra guanines (Gs) and cytosines (Cs), and configured as if it’s a human messenger RNA molecule ready to make protein by adding a polyA tail, the spike protein’s RNA sequence in the vaccine looks as if it is part bacteria,17 part human18 and part viral at the same time.
There’s also evidence suggesting the SARS-CoV-2 spike protein may be a prion, which is yet another piece of really bad news, particularly as it pertains to vaccine-induced spike protein. Prions are membrane proteins and when they misfold, they form crystals in the cytoplasm resulting in prion disease.
Since the mRNA in the vaccines has been modified to spew out very high amounts of spike protein (far greater than that of the actual virus), the risk of excessive buildup in the cytoplasm is high. And, since the spike protein doesn’t enter into the membrane of the cell, there’s a high risk that it can become problematic if indeed it works like a prion.
Remember, the aforementioned research cited by Bridle found the spike protein accumulates in the spleen, among other places. Parkinson’s disease is a prion disease that has been traced back to prions originating in the spleen, that then travel up to the brain via the vagus nerve. In the same way, it’s quite possible COVID-19 vaccines may promote Parkinson’s and other human prion diseases such as Alzheimer’s.
In short, when you get the COVID-19 vaccine, you are being injected with an agent that instructs your body to produce the bioweapon in its own cells. This is about as diabolical as it gets.
In her paper, “Worse Than The Disease: Reviewing Some Possible Unintended Consequences of mRNA Vaccines Against COVID-19,” published in the International Journal of Vaccine Theory, Practice and Research in collaboration with Dr. Greg Nigh,16 Seneff explains why the unnatural spike protein is so problematic.
In summary, normally, the spike protein on a virus will collapse on itself and fall into the cell once it attaches to the ACE2 receptor. The vaccine-induced spike protein does not do this. Instead it stays open and remains attached to the ACE2 receptor, thereby disabling it and causing a host of problems that lead to heart, lung and immune impairment.
What’s more, because the RNA code has been enriched with extra guanines (Gs) and cytosines (Cs), and configured as if it’s a human messenger RNA molecule ready to make protein by adding a polyA tail, the spike protein’s RNA sequence in the vaccine looks as if it is part bacteria,17 part human18 and part viral at the same time.
There’s also evidence suggesting the SARS-CoV-2 spike protein may be a prion, which is yet another piece of really bad news, particularly as it pertains to vaccine-induced spike protein. Prions are membrane proteins and when they misfold, they form crystals in the cytoplasm resulting in prion disease.
Since the mRNA in the vaccines has been modified to spew out very high amounts of spike protein (far greater than that of the actual virus), the risk of excessive buildup in the cytoplasm is high. And, since the spike protein doesn’t enter into the membrane of the cell, there’s a high risk that it can become problematic if indeed it works like a prion.
Remember, the aforementioned research cited by Bridle found the spike protein accumulates in the spleen, among other places. Parkinson’s disease is a prion disease that has been traced back to prions originating in the spleen, that then travel up to the brain via the vagus nerve. In the same way, it’s quite possible COVID-19 vaccines may promote Parkinson’s and other human prion diseases such as Alzheimer’s.
Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_signed_with.pdf
1.2 MB
Wodarg_Yeadon_EMA_Petition_Pfizer_Trial_FINAL_01DEC2020_signed_with_Exhibits_geschwarzt.pdf
The results from a clinical trial have been recently published in a preprint:
Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease. A pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02) (Preprint). Figueroa et al. 2021. ( https://doi.org/10.1101/2021.04.13.21255409 ).
394 participants. 196 in the intervention arm and 198 in the placebo arm. In the placebo arm there were 10 infected persons, while in the intervention arm there were 2. However, looking at the timeline, the first of the two infected in the intervention arm was positive on day 2 since randomization, so that’s probably a case of preinfection. That would leave it as 10 vs. 1 infections. The second infection in the intervention arm seems to have occurred at day 5, just as the first one in the placebo arm. I guess it’s debatable whether those can be considered preinfections or not. However, it does leave us with 9 vs. 0 infections after day 5 and in the next 20 days in this high risk cohort. So from day 5, 100% efficacy (or from day 2, 90%?). I think this trial’s results deserve some attention.
Efficacy of a nasal spray containing Iota-Carrageenan in the prophylaxis of COVID-19 in hospital personnel dedicated to patients care with COVID-19 disease. A pragmatic multicenter, randomized, double-blind, placebo-controlled trial (CARR-COV-02) (Preprint). Figueroa et al. 2021. ( https://doi.org/10.1101/2021.04.13.21255409 ).
394 participants. 196 in the intervention arm and 198 in the placebo arm. In the placebo arm there were 10 infected persons, while in the intervention arm there were 2. However, looking at the timeline, the first of the two infected in the intervention arm was positive on day 2 since randomization, so that’s probably a case of preinfection. That would leave it as 10 vs. 1 infections. The second infection in the intervention arm seems to have occurred at day 5, just as the first one in the placebo arm. I guess it’s debatable whether those can be considered preinfections or not. However, it does leave us with 9 vs. 0 infections after day 5 and in the next 20 days in this high risk cohort. So from day 5, 100% efficacy (or from day 2, 90%?). I think this trial’s results deserve some attention.